Use of Ceftriaxone as a Predictor of Good Outcome in Stroke Patients: A Retrospective Chart Review.

Priya DevVarun Kumar SinghAnand KumarRameshwar Nath ChaurasiaNeelima Alka SinghPriyanka GautamNeetu Rani DhimaniVijaya Nath MishraDeepika JoshiAbhishek Pathak

Published in: Annals of neurosciences (2022)

Stroke patients in CEFT-treated group have a better outcome compared to piperacillin-tazobactam therapy or without antibiotics use at three months. This study indicates the possibility of an additional neuroprotective effect of CEFT apart from its antibacterial property.

Keyphrases

silver nanoparticles
mesenchymal stem cells
gram negative
newly diagnosed
anti inflammatory
brain injury